
DarioHealth Corp. DRIO
$ 9.65
-6.26%
Quarterly report 2025-Q3
added 11-13-2025
DarioHealth Corp. Current Ratio 2011-2026 | DRIO
Annual Current Ratio DarioHealth Corp.
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| - | - | - | 4.85 | 4.39 | 2.58 | 2.01 | 1 | 2.54 | 1.27 | 1.95 | - | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 4.85 | 1 | 2.57 |
Current Ratio of other stocks in the Diagnostics research industry
| Issuer | Current Ratio | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
|
Agilent Technologies
A
|
2.01 | $ 121.02 | 1.7 % | $ 36.8 B | ||
|
Anixa Biosciences
ANIX
|
7.55 | $ 2.96 | 4.71 % | $ 96.1 K | ||
|
Centogene N.V.
CNTG
|
2.35 | - | -6.23 % | $ 30.6 M | ||
|
Akumin
AKU
|
1.09 | - | -17.87 % | $ 25.9 M | ||
|
Aspira Women's Health
AWH
|
1.63 | - | -6.19 % | $ 10.5 M | ||
|
Burning Rock Biotech Limited
BNR
|
5.26 | $ 22.3 | -5.27 % | $ 234 M | ||
|
Celcuity
CELC
|
1.89 | $ 111.31 | 3.64 % | $ 4.39 B | ||
|
Oxford Immunotec Global PLC
OXFD
|
15.6 | - | - | $ 562 M | ||
|
Co-Diagnostics
CODX
|
10.2 | - | - | $ 79.8 M | ||
|
Charles River Laboratories International
CRL
|
1.82 | $ 180.97 | 2.92 % | $ 8.97 B | ||
|
Castle Biosciences
CSTL
|
7.05 | $ 28.14 | 2.07 % | $ 782 M | ||
|
Accelerate Diagnostics
AXDX
|
0.745 | - | -61.36 % | $ 2.46 M | ||
|
DermTech
DMTK
|
1.88 | - | -11.32 % | $ 2.94 M | ||
|
Global Cord Blood Corporation
CO
|
2.34 | - | - | $ 399 M | ||
|
Fluidigm Corporation
FLDM
|
2.17 | - | 1.08 % | $ 308 M | ||
|
Genetic Technologies Limited
GENE
|
4.76 | - | - | $ 7.1 B | ||
|
Genetron Holdings Limited
GTH
|
2.28 | - | 0.12 % | $ 80.1 M | ||
|
Fulgent Genetics
FLGT
|
13.4 | $ 14.14 | 2.56 % | $ 428 M | ||
|
PRA Health Sciences, Inc.
PRAH
|
1.15 | - | - | $ 10.7 B | ||
|
Biodesix
BDSX
|
1.27 | $ 14.71 | -5.1 % | $ 1.91 B | ||
|
Biocept
BIOC
|
1.4 | - | -13.05 % | $ 7.29 M | ||
|
Heska Corporation
HSKA
|
3.58 | - | - | $ 1.31 B | ||
|
HTG Molecular Diagnostics
HTGM
|
1.44 | - | -20.0 % | $ 1.06 M | ||
|
BioNano Genomics
BNGO
|
1.86 | $ 1.14 | 1.88 % | $ 1.45 M | ||
|
IDEXX Laboratories
IDXX
|
1.92 | $ 650.0 | 2.28 % | $ 52.3 B | ||
|
Illumina
ILMN
|
6.69 | $ 129.59 | 0.02 % | $ 20.6 B | ||
|
Quest Diagnostics Incorporated
DGX
|
1.25 | $ 208.63 | 0.13 % | $ 23.2 B | ||
|
Danaher Corporation
DHR
|
5.19 | $ 205.32 | 0.63 % | $ 146 B | ||
|
Organovo Holdings
ONVO
|
3.52 | - | -2.3 % | $ 19.4 M | ||
|
Exact Sciences Corporation
EXAS
|
1.69 | $ 103.51 | 0.13 % | $ 19.5 B | ||
|
Bioventus
BVS
|
1.37 | $ 8.42 | -3.66 % | $ 527 M | ||
|
DexCom
DXCM
|
1.76 | $ 73.39 | 0.42 % | $ 28.6 B | ||
|
Laboratory Corporation of America Holdings
LH
|
1.89 | $ 281.11 | -0.69 % | $ 23.4 B | ||
|
QIAGEN N.V.
QGEN
|
1.88 | - | - | $ 10.6 B | ||
|
Lantheus Holdings
LNTH
|
1.96 | $ 77.74 | -1.4 % | $ 5.25 B | ||
|
ICON Public Limited Company
ICLR
|
2.29 | $ 110.81 | 1.94 % | $ 9.14 B | ||
|
CareDx, Inc
CDNA
|
3.75 | $ 19.28 | 2.56 % | $ 1.03 B | ||
|
Chembio Diagnostics
CEMI
|
1.4 | - | 0.22 % | $ 16.8 M | ||
|
Motus GI Holdings
MOTS
|
1.59 | - | -34.28 % | $ 263 K | ||
|
Check-Cap Ltd.
CHEK
|
0.206 | - | - | $ 9.42 M | ||
|
Mettler-Toledo International
MTD
|
0.994 | $ 1 290.77 | -1.92 % | $ 26.6 B | ||
|
Guardant Health
GH
|
0.953 | $ 93.95 | 0.7 % | $ 11.8 B | ||
|
Myriad Genetics
MYGN
|
2.09 | $ 5.35 | 1.04 % | $ 495 M | ||
|
IQVIA Holdings
IQV
|
1.28 | $ 177.49 | 2.0 % | $ 30.5 B | ||
|
Brainsway Ltd.
BWAY
|
2.37 | $ 12.53 | 8.11 % | $ 99.4 M | ||
|
NeoGenomics
NEO
|
2.6 | $ 9.14 | -4.25 % | $ 1.17 B | ||
|
National Research Corporation
NRC
|
1.67 | $ 13.25 | -1.05 % | $ 325 M | ||
|
Enzo Biochem
ENZ
|
2.89 | - | -8.98 % | $ 14.8 K | ||
|
Natera
NTRA
|
2.02 | $ 204.02 | -1.46 % | $ 20.1 B |